Cover Image

Diagnostic and Prognostic Value of cfDNA Concentration and Fragmentation in Prostate Cancer

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Marta Victoria Lorenzo‐Sánchez, José Miguel Giménez‐Bachs, María Granada Picazo‐Martínez, María José Donate‐Moreno, Carlos Martínez‐Sánchiz, María Amalia Tárraga‐Honrubia, Sonsoles Navarro‐Jiménez, Óscar Legido‐Gómez, Antonio Santiago Salinas‐Sánchez
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	The Prostate
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

[ 18 F] PSMA PET‐CT and [ 18 F] Choline PET‐CT in the Diagnosis of High‐Risk Localized Prostate Cancer: Comparation of Both Tests
by: M. A. Tárraga‐Honrubia, et al.
Published: (2026)

LGALS3 cfDNA methylation in seminal fluid as a novel prostate cancer biomarker outperforming PSA
by: Irena Abramovic, et al.
Published: (2024)

The Prognostic Value of the Prostate Adenocarcinoma With Ductal Feature in Patients With Advanced Prostate Cancer Treated With Abiraterone Acetate
by: Yifu Shi, et al.
Published: (2025)

Prostate Extracellular Vesicles and Prognostic Biomarkers of Clinically Significant Prostate Cancer: A Prospective Single‐Institution Pilot Study
by: Cameron J. Britton, et al.
Published: (2025)

Enhancing Diagnostic Accuracy in Prostate Oncology: A Multidimensional Perspective on Prostate Specific Antigen Density
by: Shengyi Chen, et al.
Published: (2025)

miRNAs Regulating GSTP1 as Potential Diagnostic Biomarkers in Prostate Cancer
by: Shiv Verma, et al.
Published: (2025)

Comments on the Study “Adapting the Bellmunt Risk Score for Prognostic Stratification in Metastatic Castration‐Sensitive Prostate Cancer”
by: Xian Wen
Published: (2026)

Optimizing Prostate Cancer Diagnostic Work‐Up Through Micro‐Ultrasound: Minimizing Unnecessary Procedures and Reducing Overdiagnoses
by: Edoardo Beatrici, et al.
Published: (2025)

Prostate Volume and PSA‐Density Estimation by Transabdominal Ultrasound: Prospective Evidence of Comparative Accuracy to MRI and Transrectal Ultrasound in Prostate Cancer Early Diagnostics
by: Liza M. Kurucz, et al.
Published: (2025)

Evaluating the Prognostic Impact of Apparent Diffusion Coefficient in Definitive Radiotherapy for Gleason Score 7 Prostate Cancer Patients
by: Cem Onal, et al.
Published: (2024)

Bone Metastasis Distribution Matters: Prognostic Effect of the Axial‐to‐Peripheral Ratio in Metastatic Hormone‐Sensitive Prostate Cancer
by: Ali Fuat Gürbüz, et al.
Published: (2026)

Prognostic Nutritional Index as a Biomarker in Metastatic Hormone‐Sensitive Prostate Cancer: Impact on Survival and Treatment Optimization
by: Muhammet Bekir Hacioglu, et al.
Published: (2025)

Diagnostic Performance of the Novel Biomarker S2,3PSA Density for Prostate Biopsy Optimization in Prostate Imaging Reporting and Data System 3–5 Lesions
by: Takanori Tokunaga, et al.
Published: (2025)

The Diagnostic Value of Plasma Small Extracellular Vesicle‐Derived CAIX Protein in Prostate Cancer and Clinically Significant Prostate Cancer: A Study on Predictive Models
by: Haotian Chen, et al.
Published: (2025)

Prognostic Impact of Initial Prostate Specific Antigen Half‐Life After Abiraterone Acetate in High‐Volume Metastatic Hormone‐Sensitive Prostate Cancer: Who May Need Triplet Therapy?
by: Kotaro Suzuki, et al.
Published: (2026)

A Multimarker Model for Prostate Cancer Risk Assessment: Improving Diagnostic Accuracy Beyond PSA
by: Penglu Yang, et al.
Published: (2025)

Happening in the Prostate Tumor Microenvironment: Ion Channels and Extrachromosomal DNA Driving Phenotypic Plasticity
by: Sara Darbandi, et al.
Published: (2026)

Prostate‐Specific Antigen Response at Six Months Predicts Progression in Metastatic Hormone‐Sensitive Prostate Cancer Treated With Apalutamide
by: Christian Andrés Martínez Osorio, et al.
Published: (2025)

Late Bowel Symptoms in Long‐Term Survivors of Prostate Cancer Following Radiotherapy
by: Isabella Gruber, et al.
Published: (2025)

Prostate Specific Antigen Density and Clinically‐Significant Prostate Cancer: The Influence of Prostatic Volume
by: Elizabeth Robinson, et al.
Published: (2025)

The Prognostic Significance of Radiographic Progression Without PSA Progression in Patients With Metastatic Hormone‐Sensitive Prostate Cancer Treated With First‐Line ARPI Therapy
by: Takeshi Tsutsumi, et al.
Published: (2026)

Altered Ten Eleven Translocation Methylcytosine Dioxygenase Expression and DNA Hydroxymethylation in a Mouse Model of Prostate Cancer
by: Matthew Aguilera, et al.
Published: (2025)

Prognostic Impact of Lymph Node Yield in a Phase III Clinical Trial (NRG/RTOG 9601) of Prostate Cancer Patients Treated With Salvage Radiation Following Prostatectomy
by: Emily Chan, et al.
Published: (2025)

A Two‐Factor Bedside Prognostic Score Integrating Eastern Cooperative Oncology Group (ECOG) Performance Status and Aggressive Metastatic Burden in Metastatic Hormone‐Sensitive Prostate Cancer
by: Koichiro Kurokawa, et al.
Published: (2026)

Multicenter External Validation and Optimization of a Proposed Nomogram for Prostate‐Specific Membrane Antigen PET/CT Accuracy in Biochemical Recurrence
by: Laura Chamorro Castillo, et al.
Published: (2025)

Integration of Primary Care Into the Follow‐Up Protocol for Prostate Cancer Patients in Aragon, Spain. It Is Time to Follow Other Successful Models in the Region
by: Angel Borque‐Fernando, et al.
Published: (2025)

Safety and Efficacy of Bipolar Transurethral Vaporization of the Prostate and Bipolar Transurethral Resection of the Prostate in the Management of Large Volume Benign Prostatic Hyperplasia: A Prospective Randomized Study
by: Amr M. Lotfy, et al.
Published: (2026)

Assessment of Circulating Neuroendocrine Tumor Markers at Prostate Cancer Diagnosis: An Investigation of Prostate Cancer With Neuroendocrine Features
by: Tatsuya Shimomura, et al.
Published: (2026)

Impact of Concomitant Hormone Therapy on the Diagnostic Performance of 18F‐Piflufolastat PET/CT in Prostate Cancer Patients: A Sub‐Group Analysis of OSPREY Cohort B
by: Lawrence Saperstein, et al.
Published: (2025)

Discovering the Prostate: Notes on History and Historiography
by: Diederik F. Janssen
Published: (2025)

Evidence and Rationale for Prostate Cancer Screening
by: Takeshi Takahashi
Published: (2025)

Spatial Characteristics of Intraductal Carcinoma of the Prostate
by: Rodolphe Dupuis, et al.
Published: (2025)

Prostate cancer focal therapy: surgeon experience influences oncological results
by: Claudio Bovolenta Murta, et al.
Published: (2024)

Impact of Holmium Laser Enucleation of the Prostate on Active Surveillance for Prostate Cancer in Patients With Lower Urinary Tract Symptoms
by: Charly Bâcle, et al.
Published: (2025)

Prostatic Surgery With Preservation of the Supramonticular Tissue Versus Standard Surgery for Benign Prostatic Hyperplasia: A Systematic Review
by: Giuston Mendoza‐Chuctaya, et al.
Published: (2025)

ERG and PTEN Role on Active Surveillance for Low‐Risk Prostate Cancer in the Multiparametric MRI Era
by: Marco Aurelio Watanabe Yorioka, et al.
Published: (2024)

Safety and Efficacy of Intra‐Prostatic Injection of Betamethasone for Refractory Chronic Nonbacterial Prostatitis: A Prospective Cohort Clinical Study
by: Ahmed Yehia Abdelaziz, et al.
Published: (2024)

Mycobacterium Tuberculosis: The Hidden Bacteria in Chronic Prostatitis
by: André Avarese Figueiredo, et al.
Published: (2025)

Altered Glycosylation of PSA in Prostate Cancer Tissue
by: Hannu Koistinen, et al.
Published: (2025)

Castration Resistance Accelerates Prostate Cancer Kinetics
by: Sheila Jonnatan, et al.
Published: (2026)